Pathological processes involving the PROSTATE or its component tissues.
Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
A gland in males that surrounds the neck of the URINARY BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM.
Tumors or cancer of the PROSTATE.
Infiltration of inflammatory cells into the parenchyma of PROSTATE. The subtypes are classified by their varied laboratory analysis, clinical presentation and response to treatment.
A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer.
A premalignant change arising in the prostatic epithelium, regarded as the most important and most likely precursor of prostatic adenocarcinoma. The neoplasia takes the form of an intra-acinar or ductal proliferation of secretory cells with unequivocal nuclear anaplasia, which corresponds to nuclear grade 2 and 3 invasive prostate cancer.
I'm sorry for any confusion, but the term "Virginia" is not a medical concept or condition that has a defined meaning within the medical field. It is primarily used as a proper noun to refer to a state in the United States, a historical figure, or other non-medical uses.
I'm sorry for any confusion, but "Kansas" is a geographical location and not a medical term or condition. It's a state located in the Midwestern United States. If you have any questions related to medical topics, I'd be happy to help!
A feeling of restlessness associated with increased motor activity. This may occur as a manifestation of nervous system drug toxicity or other conditions.
Type of vision test used to determine COLOR VISION DEFECTS.
A disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. (From Adams et al., Principles of Neurology, 6th ed, pp411-2)
"Awards and prizes in a medical context refer to formal recognitions, typically bestowed upon healthcare professionals or researchers, for significant contributions to medical advancements, patient care, or professional organizations, often involving monetary rewards, certificates, or trophies."
Behavior which may be manifested by destructive and attacking action which is verbal or physical, by covert attitudes of hostility or by obstructionism.

Ultrasonography as an aid in the diagnosis and management of surgical diseases of the pelvis: special emphasis on the genitourinary system. (1/148)

Technological advances, particularly the advent of the gray scale technique, has greatly extended the application and usefulness of this modality to clinical diagnoses and surgery. The ultrasonic beam uniquely provides anatomical profiles in the transverse (cross-sectional) and sagittal (longitudinal) planes of the body. Intra-rectal and intra-vaginal ultrasonic probes have provided unique definition of both the normal and pathologic anatomy of the pelvic organs. The present report is drawn from a continuing experience with ultrasonography of the genitourinary system with an update of current technological advances. Ultrasonography has proven especially valuable in the following clinical applications: 1) Early diagnosis of cancer (especially of the prostate); 2) Accurate staging of cancer of the bladder and prostate; 3) Monitoring of the response of the pathologic process to therapy.  (+info)

Estrogen receptor expression in prostate cancer and premalignant prostatic lesions. (2/148)

Estrogens have been implicated in prostatic cancerogenesis and tumor progression. The mechanisms underlying estrogen signaling in human prostate tissue, however, remain poorly understood. Using immunohistochemical and in situ hybridization (ISH) techniques, the present study demonstrates the classical estrogen receptor (ERalpha) in premalignant lesions and prostatic adenocarcinoma through the various stages of the disease. Conversely, the novel characterized ERbeta subtype was undetectable in human prostate tissue. High-grade prostatic intraepithelial neoplasia revealed ERalpha mRNA and protein expression in 28% and 11% of cases evaluated. Focal ER immunoreactivity was detected in a minority of low- to intermediate-grade adenocarcinoma. High-grade (primary Gleason grade 4 and 5) tumors revealed ER protein expression in 43% (62% respectively) of cases. The most significant ERalpha gene expression on mRNA and protein levels was observed in hormone refractory tumors and metastatic lesions, including lymph node and bone metastases. Results of the current study suggest that estrogens can affect prostatic cancerogenesis and neoplastic progression through an ER-mediated process in human prostate tissue.  (+info)

Transurethral deroofing of midline prostatic cyst for subfertile men. (3/148)

We evaluated the efficacy of transurethral deroofing of a midline prostatic cyst in subfertile men with one or more of the following semen abnormalities: decreased ejaculatory volume, decreased sperm motility and oligo- or azoospermia. Results from treatment of a series of 11 subfertile men with a midline prostatic cyst by transurethral deroofing of the cyst are presented. Five patients showed an improvement of seminal volume. Only one patient demonstrated an improvement of sperm count. Sperm motility was not influenced. No relationship was found between positive outcome following operation and either size of the cyst or dilatation of the seminal vesicles. Spontaneous pregnancies did not occur after transurethral deroofing of the midline prostatic cyst. In conclusion, our study suggests a poor efficacy of transurethral deroofing of a midline prostatic cyst in subfertile men with the above mentioned semen abnormalities.  (+info)

Prostatic and central nervous system histoplasmosis in an immunocompetent host: case report and review of the prostatic histoplasmosis literature. (4/148)

Histoplasmosis is a common cause of systemic mycosis in areas of the United States where it is endemic. Central nervous system and genitourinary histoplasmosis is rare, especially in immunocompetent hosts. We describe a case of disseminated histoplasmosis in a normal host that was associated with cerebral and prostatic histoplasmosis presenting as fever of undetermined origin, weight loss, and severe debilitating altered mental status. The patient subsequently developed acute renal failure that manifested as obstructive uropathy during antifungal therapy with amphotericin B. Transurethral resection of the prostate resulted in improved renal function during continuation of amphotericin B therapy. Pathological analysis of the prostate revealed necrotizing granulomas with intralesional fungal organisms. Blood and urine cultures were positive for Histoplasma capsulatum. Diagnostic issues and management are discussed. Treatment resulted in return of normal cognitive and motor function. This case is compared with the 8 previously reported cases of H. capsulatum prostatitis.  (+info)

Can percent free prostate-specific antigen reduce the need for prostate biopsy? (5/148)

BACKGROUND: In a recent multicenter study, percent free prostate-specific antigen (PSA) enhanced the specificity of PSA testing in prostate cancer screening. OBJECTIVE: To determine whether the percent free PSA could be as effective in reducing the need for biopsy in a managed care setting as in an academic setting. SETTING: Kaiser Permanente Northwest Region (Portland, Oregon) and Kaiser Permanente Oakland/Berkeley (California). DESIGN: Prospective blinded study conducted by using Hybritech Tandem PSA and Hybritech Tandem free PSA assays (Beckman Coulter, Inc., Fullerton, California). PARTICIPANTS: 250 men (63 with prostate cancer and 187 with benign prostate conditions) who were older than 40 years of age, had a PSA level of 4.0 to 10.0 ng/mL, and had a histologically confirmed diagnosis. MAIN OUTCOME MEASURES: Sensitivity and specificity of percent free PSA. RESULTS: The median percent free PSA values for patients with cancer (free PSA, 13%) significantly differed from that for patients without cancer (free PSA, 17%) (P = 0.001). When a free PSA cutoff of 25% was used, the sensitivity was 97% (95% CI, 92% to 100%) and the specificity was 13% (CI, 8% to 18%). These results were not significantly different from those obtained in the multicenter study (95% sensitivity, 20% specificity for a free PSA cutoff of 25%). CONCLUSION: The results obtained in a managed care organization were similar to those obtained at large university medical centers and show that the percent free PSA can be used to enhance the specificity of PSA testing for prostate cancer.  (+info)

Treatment of prostatitis. (6/148)

The term prostatitis is applied to a series of disorders, ranging from acute bacterial infection to chronic pain syndromes, in which the prostate gland is inflamed. Patients present with a variety of symptoms, including urinary obstruction, fever, myalgias, decreased libido or impotence, painful ejaculation and low-back and perineal pain. Physical examination often fails to clarify the cause of the pain. Cultures and microscopic examination of urine and prostatic secretions before and after prostatic massage may help differentiate prostatitis caused by infection from prostatitis with other causes. Because the rate of occult infection is high, a therapeutic trial of antibiotics is often in order even when patients do not appear to have bacterial prostatitis. If the patient responds to therapy, antibiotics are continued for at least three to four weeks, although some men require treatment for several months. A patient who does not respond might be evaluated for chronic nonbacterial prostatitis, in which nonsteroidal anti-inflammatory drugs, alpha-blocking agents, anticholinergic agents or other therapies may provide symptomatic relief.  (+info)

Health issues in men: part I: Common genitourinary disorders. (7/148)

Common genitourinary health issues that arise in the care of male patients include prostatitis, benign prostatic hyperplasia, urogenital cancers, premature ejaculation and erectile dysfunction. Bacterial infections are responsible for only 5 to 10 percent of prostatitis cases. Benign prostatic hyperplasia is present in 90 percent of men by the age of 85. Common urogenital cancers include prostate cancer, transitional cell carcinoma of the bladder and testicular cancer. Although an estimated 10 percent of men eventually develop prostate cancer, screening for this malignancy is one of the most controversial areas of health prevention. Premature ejaculation occurs in as many as 40 percent of men. Treatment with tricyclic antidepressants, selective serotonin reuptake inhibitors, counseling or behavioral therapy may be helpful. Erectile dysfunction affects up to 30 percent of men between 40 and 70 years of age. Stepped therapy is a useful approach to this common malady. Good treatment results have been obtained with orally administered sildenafil and intraurethrally administered alprostadil.  (+info)

Successful closure of a recto-prostatic fistula. (8/148)

Recto-prostatic fistula is a rare complication of prostatic surgery, occurring usually because surgical planes are not appreciated. We describe a combined abdomino-perineal approach for the repair of a large recto-prostatic fistula with the interposition of omentum and gracilis without formally closing the fistula in layers.  (+info)

Prostatic diseases refer to a range of medical conditions that affect the prostate gland, a small gland that is part of the male reproductive system. The prostate is located below the bladder and surrounds the urethra, the tube that carries urine and semen out of the body. Some common prostatic diseases include:

1. Benign Prostatic Hyperplasia (BPH): This is a non-cancerous enlargement of the prostate gland that can cause difficulties with urination, such as a weak stream, frequent urination, and a feeling of incomplete bladder emptying.
2. Prostatitis: This is an inflammation or infection of the prostate gland that can cause pain, fever, difficulty urinating, and sexual dysfunction.
3. Prostate Cancer: This is a malignant tumor that develops in the prostate gland and can spread to other parts of the body. It is one of the most common types of cancer in men and can often be treated successfully if detected early.
4. Acute Bacterial Prostatitis: This is a sudden and severe infection of the prostate gland that can cause fever, chills, pain in the lower back and genital area, and difficulty urinating.
5. Chronic Bacterial Prostatitis: This is a recurring or persistent bacterial infection of the prostate gland that can cause symptoms similar to chronic pelvic pain syndrome.
6. Chronic Pelvic Pain Syndrome (CPPS): Also known as chronic nonbacterial prostatitis, this condition is characterized by ongoing pain in the pelvic area, often accompanied by urinary and sexual dysfunction. The exact cause of CPPS is not well understood, but it is thought to be related to inflammation or nerve damage in the prostate gland.

Prostatic hyperplasia, also known as benign prostatic hyperplasia (BPH), is a noncancerous enlargement of the prostate gland. The prostate gland surrounds the urethra, the tube that carries urine and semen out of the body. When the prostate gland enlarges, it can squeeze or partially block the urethra, causing problems with urination, such as a weak stream, difficulty starting or stopping the flow, and more frequent urination, especially at night. Prostatic hyperplasia is a common condition as men age and does not necessarily lead to cancer. However, it can cause significant discomfort and decreased quality of life if left untreated. Treatment options include medications, minimally invasive procedures, and surgery.

The prostate is a small gland that is part of the male reproductive system. Its main function is to produce a fluid that, together with sperm cells from the testicles and fluids from other glands, makes up semen. This fluid nourishes and protects the sperm, helping it to survive and facilitating its movement.

The prostate is located below the bladder and in front of the rectum. It surrounds part of the urethra, the tube that carries urine and semen out of the body. This means that prostate problems can affect urination and sexual function. The prostate gland is about the size of a walnut in adult men.

Prostate health is an important aspect of male health, particularly as men age. Common prostate issues include benign prostatic hyperplasia (BPH), which is an enlarged prostate not caused by cancer, and prostate cancer, which is one of the most common types of cancer in men. Regular check-ups with a healthcare provider can help to detect any potential problems early and improve outcomes.

Prostatic neoplasms refer to abnormal growths in the prostate gland, which can be benign or malignant. The term "neoplasm" simply means new or abnormal tissue growth. When it comes to the prostate, neoplasms are often referred to as tumors.

Benign prostatic neoplasms, such as prostate adenomas, are non-cancerous overgrowths of prostate tissue. They usually grow slowly and do not spread to other parts of the body. While they can cause uncomfortable symptoms like difficulty urinating, they are generally not life-threatening.

Malignant prostatic neoplasms, on the other hand, are cancerous growths. The most common type of prostate cancer is adenocarcinoma, which arises from the glandular cells in the prostate. Prostate cancer often grows slowly and may not cause any symptoms for many years. However, some types of prostate cancer can be aggressive and spread quickly to other parts of the body, such as the bones or lymph nodes.

It's important to note that while prostate neoplasms can be concerning, early detection and treatment can significantly improve outcomes for many men. Regular check-ups with a healthcare provider are key to monitoring prostate health and catching any potential issues early on.

Prostatitis is a medical condition that refers to inflammation of the prostate gland, which can be caused by bacterial or non-bacterial factors. It can present with various symptoms such as pain in the lower abdomen, pelvis, or genital area, difficulty and/or painful urination, ejaculation pain, and flu-like symptoms. Prostatitis can be acute or chronic, and it is important to seek medical attention for proper diagnosis and treatment.

Prostate-Specific Antigen (PSA) is a glycoprotein enzyme produced by the epithelial cells of the prostate gland. It is primarily involved in liquefying semen after ejaculation, allowing sperm mobility.

In clinical medicine, PSA is used as a tumor marker, mainly for monitoring the treatment and recurrence of prostate cancer. Elevated levels of PSA can indicate inflammation, infection, benign prostatic hyperplasia (BPH), or prostate cancer. However, it's important to note that an elevated PSA level does not necessarily confirm cancer; further diagnostic tests like digital rectal examination, transrectal ultrasound, and prostate biopsy are often required for definitive diagnosis.

Doctors may also use PSA isoforms or derivatives, such as free PSA, total PSA, and PSA density, to help improve the specificity of cancer detection and differentiate between malignant and benign conditions.

Prostatic Intraepithelial Neoplasia (PIN) is a term used in pathology to describe the abnormal growth of cells within the lining of the prostate gland's ducts and acini (small sacs that produce and store fluids). PIN is not considered a cancer, but it can be a precursor to prostate cancer.

There are two types of PIN: low-grade and high-grade. Low-grade PIN shows mild to moderate atypia (abnormalities in the cells), while high-grade PIN displays more significant atypia, which resembles prostate cancer. High-grade PIN is often found close to or within areas of prostate cancer, making it a potential indicator of malignancy.

However, not all cases of high-grade PIN progress to cancer, and some men with high-grade PIN may never develop prostate cancer. Nonetheless, the presence of high-grade PIN might prompt further investigation or monitoring to ensure early detection and treatment of any potential cancer development.

I'm sorry for any confusion, but "Virginia" is not a medical term or condition. It is a geographical location, specifically the name of a state in the United States. If you have any medical questions or terms you would like defined, I'd be happy to help!

I'm sorry for any confusion, but "Kansas" is not a medical term. It is a geographical location, being the name of a state in the central United States. If you have any questions about medical terms or conditions, I would be happy to help answer those!

Psychomotor agitation is a state of increased physical activity and purposeless or semi-purposeful voluntary movements, usually associated with restlessness, irritability, and cognitive impairment. It can be a manifestation of various medical and neurological conditions such as delirium, dementia, bipolar disorder, schizophrenia, and substance withdrawal. Psychomotor agitation may also increase the risk of aggressive behavior and physical harm to oneself or others. Appropriate evaluation and management are necessary to address the underlying cause and alleviate symptoms.

Color perception tests are a type of examination used to evaluate an individual's ability to perceive and distinguish different colors. These tests typically consist of a series of plates or images that contain various patterns or shapes displayed in different colors. The person being tested is then asked to identify or match the colors based on specific instructions.

There are several types of color perception tests, including:

1. Ishihara Test: This is a commonly used test for red-green color deficiency. It consists of a series of plates with circles made up of dots in different sizes and colors. Within these circles, there may be a number or symbol visible only to those with normal color vision or to those with specific types of color blindness.
2. Farnsworth D-15 Test: This test measures an individual's ability to arrange colored caps in a specific order based on their hue. It is often used to diagnose and monitor the progression of color vision deficiencies.
3. Hardy-Rand-Rittler (HRR) Test: This is another type of color arrangement test that measures an individual's ability to distinguish between different colors based on their hue, saturation, and brightness.
4. Color Discrimination Tests: These tests measure an individual's ability to distinguish between two similar colors that are presented side by side or in close proximity.
5. Anomaloscope Test: This is a more sophisticated test that measures the degree of color vision deficiency by asking the person to match the brightness and hue of two lights.

Color perception tests are often used in occupational settings, such as aviation, military, and manufacturing, where color discrimination is critical for safety and performance. They may also be used in educational and clinical settings to diagnose and monitor color vision deficiencies.

Delirium is a serious disturbance in mental abilities that results in confused thinking and reduced awareness of the environment, which can cause people to be easily distracted and unable to focus on any one topic for very long. It can also lead to rapid changes in emotions, perception, behavior, sleep-wake cycle, and hallucinations. Delirium is caused by various underlying medical conditions, such as infection, illness, or medication side effects, and it can be a symptom of severe illness or brain disorder. It can develop quickly, often over the course of hours or days, and it may come and go.

Delirium is different from dementia, which is a chronic and progressive decline in cognitive abilities, although delirium can occur in people with dementia. Delirium is also different from a mental illness such as schizophrenia, which involves persistent disturbances in thinking and perception that are not caused by a medical condition or medication.

Delirium is a serious medical condition that requires immediate evaluation and treatment. If you suspect someone may have delirium, it's important to seek medical attention right away.

"Awards and prizes" in a medical context generally refer to recognitions given to individuals or organizations for significant achievements, contributions, or advancements in the field of medicine. These can include:

1. Research Awards: Given to researchers who have made significant breakthroughs or discoveries in medical research.
2. Lifetime Achievement Awards: Recognizing individuals who have dedicated their lives to advancing medicine and healthcare.
3. Humanitarian Awards: Presented to those who have provided exceptional service to improving the health and well-being of underserved populations.
4. Innovation Awards: Given to recognize groundbreaking new treatments, technologies, or approaches in medicine.
5. Educator Awards: Honoring medical educators for their contributions to teaching and mentoring future healthcare professionals.
6. Patient Care Awards: Recognizing excellence in patient care and advocacy.
7. Public Health Awards: Given for outstanding work in preventing disease and promoting health at the population level.
8. Global Health Awards: Honoring those who have made significant contributions to improving health outcomes in low-resource settings around the world.

These awards can be given by various organizations, including medical societies, hospitals, universities, pharmaceutical companies, and government agencies.

Aggression is defined in medical terms as behavior that is intended to cause harm or damage to another individual or their property. It can take the form of verbal or physical actions and can be a symptom of various mental health disorders, such as intermittent explosive disorder, conduct disorder, antisocial personality disorder, and dementia. Aggression can also be a side effect of certain medications or a result of substance abuse. It is important to note that aggression can have serious consequences, including physical injury, emotional trauma, and legal repercussions. If you or someone you know is experiencing problems with aggression, it is recommended to seek help from a mental health professional.

... is a quarterly peer-reviewed medical journal covering all aspects of prostatic diseases ... Prostate Cancer and Prostatic Diseases is of interest to surgeons, oncologists and clinicians treating patients and to those ... Freedland, S J (September 2010). "Editor's comments". Prostate Cancer and Prostatic Diseases. 13 (3): 203. doi:10.1038/pcan. ... involved in research into diseases of the prostate. The journal covers the three main areas - prostate cancer, male LUTS and ...
... has been associated with prostate disease, which can progress due to age. Oftentimes, the prostate will ... "Prostate Diseases". medlineplus.gov. 2016. Retrieved 28 July 2022. Joseph MK (1980). "Bangshil and Fortege in prostatic ... Benign prostatic hyperplasia (BPH) - The testicular and prostatic veins are connected. According to Bernoulli's and Pascal's ... Paz GF, Fainman N, Homonnai ZT, Kraicer PF (1980). "The effect of massage treatment of prostatic congestion on the prostatic ...
Page 83 in: Herbert Lepor (2000). Prostatic Diseases. W.B. Saunders Company. ISBN 9780721674162. Birur, N. Praveen; Patrick, ... 2014). "Hounsfield unit values of retropharyngeal abscess-like lesions seen in Kawasaki disease". Acta Oto-Laryngologica. 134 ( ...
May 2016). "Benign prostatic hyperplasia". Nature Reviews. Disease Primers. 2 (1): 16031. doi:10.1038/nrdp.2016.31. PMID ... prostatic tissue (NNT). B. Benign prostatic hyperplasia. C. High-grade prostatic intraepithelial neoplasia. D. Prostatic ... Santillo VM, Lowe FC (2006). "Treatment of benign prostatic hyperplasia in patients with cardiovascular disease". Drugs & Aging ... Benign prostatic hyperplasia is an age-related disease. Misrepair-accumulation aging theory suggests that development of benign ...
Prostate Cancer and Prostatic Diseases. 8 (3): 260-5. doi:10.1038/sj.pcan.4500817. PMID 15999119. Ochiai T, Sugitani M, ...
Prostate Cancer and Prostatic Diseases. 13 (2): 126-131. doi:10.1038/pcan.2009.64. PMID 20084081. S2CID 25050759. Mair R, ... Increased mtDNA damage is a feature of several neurodegenerative diseases. The brains of individuals with Alzheimer's disease ... Bonda DJ, Wang X, Lee HG, Smith MA, Perry G, Zhu X (April 2014). "Neuronal failure in Alzheimer's disease: a view through the ... These diseases do not follow mitochondrial inheritance patterns, but instead follow Mendelian inheritance patterns. Recently a ...
Prostate Cancer and Prostatic Diseases. 9 (1): 83-91. doi:10.1038/sj.pcan.4500837. PMID 16276351. POU4F1+protein,+human at the ... whereas diseases are associated with several other members of the POU domain transcription factor class. POU4F1 has been shown ... and dosage compensation in heterozygotes may explain why POU4F1 mutations have not been identified in any human disease, ...
Prostate Cancer and Prostatic Diseases. 2 (3): 159-162. doi:10.1038/sj.pcan.4500308. PMID 12496826. Ateya A, Fayez A, Hani R, ... Prostatic massage should never be performed on patients with acute prostatitis, because the infection can spread elsewhere in ... Anal eroticism Anal sex Nickel JC, Downey J, Feliciano AE, Hennenfent B (1999). "Repetitive prostatic massage therapy for ... Shoskes DA, Zeitlin SI (1999). "Use of prostatic massage in combination with antibiotics in the treatment of chronic ...
... a role in prostatic disease?" (PDF). BJU International. 94 (7): 985-9. doi:10.1111/j.1464-410X.2004.05091.x. PMID 15541114. ... Prostate Cancer and Prostatic Diseases. 7 (1): 21-31. doi:10.1038/sj.pcan.4500684. PMID 14999234. Aalberts, Marian; Stout, Tom ... Ronquist G, Brody I, Gottfries A, Stegmayr B (1978). "An Mg2+ and Ca2+-stimulated adenosine triphosphatase in human prostatic ... Ronquist G, Brody I, Gottfries A, Stegmayr B (1978). "An Mg2+ and Ca2+-stimulated adenosine triphosphatase in human prostatic ...
Prostate Cancer and Prostatic Diseases. 1 (3): 128-133. doi:10.1038/sj.pcan.4500226. PMID 12496905. Cacioppo, John T.; Norris, ... the most important disease-specific distress for patients with prostate cancer". Br. J. Cancer. 73 (11): 1417-1421. doi:10.1038 ...
2006). "Quantitative expression profile of PSGR in prostate cancer". Prostate Cancer and Prostatic Diseases. 9 (1): 56-61. doi: ...
Prostate Cancer and Prostatic Diseases. 1 (3): 128-33. doi:10.1038/sj.pcan.4500226. PMID 12496905. Helgason ÁR, Dickman PW, ... The risk of disease progression and metastasis (spread of the cancer) may be increased, but this increase risk appears to be ... Neutrons have been shown to be superior to X-rays in the treatment of prostatic cancer. The rationale is that tumours ... The favored treatment option depends on the stage of the disease, the Gleason score, and the PSA level. Other important factors ...
Prostate Cancer and Prostatic Diseases. 1998: 1:128-133. Helgason ÁR, Dickman PW, Adolfsson J, Steineck G. Emotional isolation ... Helgason ÁR, Adolfsson J, Dickman P, Fredrikson M, Arver S, Steineck G. Waning sexual function - the most important disease- ...
Prostate Cancer and Prostatic Diseases. 25 (1): 11-26. doi:10.1038/s41391-021-00394-5. PMID 34050265. S2CID 235241529. Mena, ... "Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings". Cancer Imaging. 20 (1): 23. doi: ...
Labrie F, Dupont A, Belanger A, Lachance R (October 1987). "Flutamide eliminates the risk of disease flare in prostatic cancer ... Prostate Cancer and Prostatic Diseases. 1 (6): 307-314. doi:10.1038/sj.pcan.4500262. PMID 12496872. S2CID 33497597. William ... Dose-ranging studies of flutamide in men with benign prostatic hyperplasia and prostate cancer alone and in combination with a ... Scher, Howard I. (2005). "Hyperplastic and Malignant Diseases of the Prostate". In Dennis L. Kasper, Anthony S. Fauci, Dan L. ...
Prostate Cancer and Prostatic Diseases. 24 (4): 962-975. doi:10.1038/s41391-021-00368-7. ISSN 1476-5608. PMID 33927357. S2CID ... The first human vasectomies were performed to treat benign prostatic hyperplasia, or enlargement of the prostate. Castration ...
Prostate Cancer and Prostatic Diseases. 17 (4): 343-7. doi:10.1038/pcan.2014.33. PMC 4227889. PMID 25179590. Ting F, Tran M, ... Prostate Cancer and Prostatic Diseases. 19 (1): 46-52. doi:10.1038/pcan.2015.47. PMID 26458959. S2CID 6206548. Blazevski A, ... Disease progression was seen in 14 of 23 patients (61%). Stable disease was found in 1 (4%), partial remission in 1 (4%) and ... October 2015). "Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical ...
Prostate Cancer and Prostatic Diseases. 8 (1): 91-4. doi:10.1038/sj.pcan.4500784. PMID 15711607. James VH, Pasqualini JR (22 ... Hepatic failure and interstitial lung disease (see WARNINGS AND PRECAUTIONS) have been observed in post-marketed data and fatal ... 79-. ISBN 978-1-4939-1176-9. Resnick MI, Thompson IM (2000). Advanced Therapy of Prostate Disease. PMPH-USA. pp. 379-. ISBN 978 ... R 1881 binding to the prostatic androgen receptor and [3H]5 alpha-dihydrotestosterone and [3H]cortisol binding to plasma ...
Prostate Cancer and Prostatic Diseases. 16 (3): 277-84. doi:10.1038/pcan.2013.18. PMC 3763935. PMID 23835622. Bhattacharyya S, ... The disease is usually diagnosed in infants between one and five years of age. Galsulfase has been shown to improve walking and ... This causes the signs of the disease, the most noticeable being a short body, a large head and difficulty moving about. ... Ferreira CR, Gahl WA (May 2017). "Lysosomal storage diseases". Transl Sci Rare Dis. 2 (1-2): 1-71. doi:10.3233/TRD-160005. PMC ...
Prostate Cancer and Prostatic Diseases. 8 (1): 91-4. doi:10.1038/sj.pcan.4500784. PMID 15711607. Erem C (2013). "Update on ... Bicalutamide has been studied in the treatment of benign prostatic hyperplasia (BPH) in a 24-week trial of 15 patients at a ... Fox JG, Marini RP (26 March 2014). Biology and Diseases of the Ferret. Wiley. p. 980. ISBN 978-1-118-78273-6. Other agents have ... Wilson CB, Nizet V, Maldonado Y, Klein JO, Remington JS (2015). Remington and Klein's Infectious Diseases of the Fetus and ...
Prostate Cancer and Prostatic Diseases. 13 (1): 71-7. doi:10.1038/pcan.2009.42. PMC 2834351. PMID 19786982. Yaghi MD, Kehinde ... PSA screening is controversial as PSA may become elevated due to non-cancerous conditions such as benign prostatic hyperplasia ... and decreased the diagnosis of insignificant or low-risk disease by 89.4%. Two methods of MRI-guided, or "targeted" prostate ...
Prostate Cancer and Prostatic Diseases. 8 (1): 91-4. doi:10.1038/sj.pcan.4500784. PMID 15711607. S2CID 9151853. Schulze H, ... Liver diseases and liver dysfunction Chronic kidney disease Dubin-Johnson syndrome and Rotor syndrome History of jaundice or ... It is used at very high doses by mouth or by intramuscular injection to treat this disease. Antiandrogens do not cure prostate ... CPA has been studied as a form of androgen deprivation therapy for the treatment of benign prostatic hyperplasia (enlarged ...
Prostate Cancer and Prostatic Diseases. 8 (3): 215-218. doi:10.1038/sj.pcan.4500818. PMID 15999118. S2CID 20871409. Li MX, Tang ... It is used to treat benign prostatic hyperplasia (BPH). As the name indicates, it is performed by visualising the prostate ... Retrograde ejaculation due to injury of the prostatic urethra. This is one of the most frequent complications of the procedure ... Transurethral resection of the prostate (commonly known as a TURP, plural TURPs, and rarely as a transurethral prostatic ...
Prostate Cancer and Prostatic Diseases. doi:10.1038/S41391-019-0181-Y. ISSN 1365-7852. PMID 31776447. Wikidata Q91496974. ... is focussed on the genetic causes of prostate cancer and identifying patients with increased risk of developing the disease. ...
Prostate Cancer and Prostatic Diseases. 26 (2): 293-301. doi:10.1038/s41391-022-00491-z. ISSN 1476-5608. PMID 35046557. S2CID ... In CAH patients with poor disease control, 11-oxygenated androgens remain elevated for longer than 17-OHP, thus serving as a ... and Resurrection of 11-Oxygenated Androgens in Human Physiology and Disease". Horm Res Paediatr. 89 (5): 284-291. doi:10.1159/ ... better biomarker for the effectiveness of the disease control. In males with CAH, 11-oxygenated androgen levels may indicate ...
Prostate Cancer and Prostatic Diseases. 23 (4): 696-704. doi:10.1038/s41391-020-0219-1. ISSN 1365-7852. PMC 7655502. PMID ...
Prostate Cancer and Prostatic Diseases. 23 (4): 696-704. doi:10.1038/s41391-020-0219-1. ISSN 1365-7852. PMC 7655502. PMID ...
Prostate Cancer and Prostatic Diseases. 8 (1): 91-94. doi:10.1038/sj.pcan.4500784. PMID 15711607. S2CID 9151853. Wolfgang ... Prostate Cancer and Prostatic Diseases. 1 (6): 307-314. doi:10.1038/sj.pcan.4500262. PMID 12496872. S2CID 33497597. ... Bagatelle C, Bremner WJ (27 May 2003). Androgens in Health and Disease. Springer Science & Business Media. pp. 25-. ISBN 978-1- ... While effective in slowing the progression of the disease initially, most advanced prostate cancer patients eventually become ...
Prostate Cancer and Prostatic Diseases. 23 (4): 696-704. doi:10.1038/s41391-020-0219-1. ISSN 1365-7852. PMC 7655502. PMID ... Comparing HIIT to moderate intensity continuous training (MICT) in people with coronary artery disease, HIIT leads to greater ... coronary artery disease, or metabolic syndrome) who completed a HIIT exercise program can be nearly double that of individuals ... particularly if there is a history of coronary heart disease. This is to ascertain its safety and allow the patient to build up ...
Prostate Cancer and Prostatic Diseases. 23 (4): 718-723. doi:10.1038/s41391-020-0251-1. PMC 7666085. PMID 32661432. Mathur D, ... Dai L, Wei XN, Zheng DH, Mo YQ, Pessler F, Zhang BY (June 2011). "Effective treatment of Kimura's disease with leflunomide in ... Holtmann MH, Gerts AL, Weinman A, Galle PR, Neurath MF (April 2008). "Treatment of Crohn's disease with leflunomide as second- ... Prajapati DN, Knox JF, Emmons J, Saeian K, Csuka ME, Binion DG (August 2003). "Leflunomide treatment of Crohn's disease ...
Prostate Cancer and Prostatic Diseases (Prostate Cancer Prostatic Dis) ISSN 1476-5608 (online) ISSN 1365-7852 (print) ... The Editor of Prostate Cancer and Prostatic Diseases is proud to share a selection of key papers that have published in the ... In this virtual issue of Prostate Cancer and Prostatic Diseases entitled "Best of Asia", the journals Editor-in-Chief, Dr. ... Alpha1 Blockers in Benign Prostatic Disease (BPH) Treatment: Towards the Next Millennium and Beyond The satellite symposium was ...
Prostate Cancer and Prostatic Diseases is a quarterly peer-reviewed medical journal covering all aspects of prostatic diseases ... Prostate Cancer and Prostatic Diseases is of interest to surgeons, oncologists and clinicians treating patients and to those ... Freedland, S J (September 2010). "Editors comments". Prostate Cancer and Prostatic Diseases. 13 (3): 203. doi:10.1038/pcan. ... involved in research into diseases of the prostate. The journal covers the three main areas - prostate cancer, male LUTS and ...
... benign prostatic hyperplasia) including drug and non-drug BPH treatment and BPH surgery for benign prostatic hyperplasia or ... Benign Prostatic Hyperplasia (BPH) : Review in-depth clinical information, latest medical news, and guidelines on BPH ( ... 5-Alpha Reductase Inhibitors in Prostatic Disease and Beyond. Translational Andrology and Urology May 22, 2023 ...
... answers are found in the Diseases and Disorders powered by Unbound Medicine. Available for iPhone, iPad, Android, and Web. ... Benign Prostatic Hyperplasia (Hypertrophy) [Internet]. In: Diseases and Disorders. F.A. Davis Company; 2019. [cited 2023 ... Sommers, M. S. (2019). Benign Prostatic Hyperplasia (Hypertrophy). In Diseases and Disorders (6th ed.). F.A. Davis Company. ... Sommers, Marilyn Sawyer.. "Benign Prostatic Hyperplasia (Hypertrophy)." Diseases and Disorders, 6th ed., F.A. Davis Company, ...
Genital Diseases, Male - Prostatic Neoplasms PubMed MeSh Term *Overview. Overview. subject area of * A basal-enriched microRNA ... Diffuse Reflectance Spectroscopy Can Differentiate High Grade and Low Grade Prostatic Carcinoma Conference Proceeding ...
A neurological disorder, such as Parkinsons disease or multiple sclerosis.. Any type of prostate procedure can cause side ... Our caring team of Mayo Clinic experts can help you with your benign prostatic hyperplasia (bph)-related health concerns Start ... Benign prostatic hyperplasia: Etiology, pathophysiology, epidemiology, and natural history. In: Campbell-Walsh-Wein Urology. ... Evaluation and nonsurgical management of benign prostatic hyperplasia. In: Campbell-Walsh Urology. 12th ed. Elsevier; 2021. ...
Disease - Prostate Disorders - Pathology for Medicine faster and easier with Picmonics unforgettable videos, stories, and ... Benign Prostatic Hyperplasia (BPH) Disease. Quiz. Picmonics rapid review multiple-choice quiz allows you to assess your ...
The device for the first time employ body energy to treat chronic prostatic diseases effectively. Dr Allens Device ... Benign Prostatic hyperplasia (BPH) and Prostatitis Treatment via Dr Allens Device. Deccan Chronicle. ,. DC Correspondent ... Dr Allens Device is used as self-management tool for non-cancerous prostate diseases treatment at home protecting men with BPH ... Thermobalancing therapy and Dr Allens Device for the first time employ body energy to treat chronic prostatic diseases ...
Prostatic Disease: A Common Problem / New Hope for Relief. *Post author:Thomas Kruzel ... Contrary to belief, benign prostatic hypertrophy does not necessarily develop into prostatic cancer, the second leading form of ... Prostatic cancer is the second leading form of cancer in men in the Unites States. Reluctance to undergo examination on the ... Prostatic specific antigen is also elevated with cancer of the prostate but is not diagnostic of that condition. Used in ...
Evaluation of serum Chromogranin A levels in different prostatic diseases Apolihin O.I., Sivkov A.V., Efremov G.D., Rabinovich ... 2012 we have started an epidemiological study with the aim of the evaluation of ChA level value in different prostatic diseases ... NED presence in these cases could be the sign of more aggressive disease. This statement finds support in the performed studies ... Principles of «4P Medicine» in the organization of health care in the context of urological diseases Changes in the electrolyte ...
A medicine for prostatic hyperplasia could help slow the progression of Parkinsons disease ... A medicine for prostatic hyperplasia could help slow the progression of Parkinsons disease ... Parkinsons disease (PD) is an old age disorder that causes a series of motor deficiencies that are characteristic. Normally, ... In the case of those affected by Parkinsons disease, a reduction in the levels of ATP and mitochondrial biogenesis, as well as ...
... Information ... Benign Prostatic Hypertrophy; Prostate Disease; Prostate Enlargement; Prostatitis BPH. A benign (noncancerous) condition in ...
Prostate Cancer and Prostatic Diseases. 8 (3): 260-5. doi:10.1038/sj.pcan.4500817. PMID 15999119. Ochiai T, Sugitani M, ...
Benign Prostatic Hyperplasia (BPH) (Mayo Foundation for Medical Education and Research) * Prostatitis: Inflammation of the ... How are prostate diseases diagnosed?. To find out if you have a prostate problem, your provider will:. *Ask about your medical ... National Institute of Diabetes and Digestive and Kidney Diseases) * Prostate-Specific Antigen (PSA) Test (National Cancer ... Who is more likely to develop prostate diseases?. Anyone with a prostate can develop prostate problems. But some people are at ...
Prostate Cancer and Prostatic Diseases. Malouff T, Mathy NW, Marsh S, Walters RW, Silberstein PT. Trends in the use of ... Sickle Cell Disease Is A Prognostic Indicator Of Increased In-Hospital Mortality In Heart Failure Admissions: Results Of A ... Digestive Disease Week, May 2015. Poster Presentation 2015. *Immunotherapy in Stage III Melanoma: A Population-Based Analysis ... Prostate Cancer Prostatic Dis. 2017 Apr 11. doi: 10.1038/pcan.2017.15. [Epub ahead of print] PMID: 28398296 2017 ...
Bio-Techne Announces ExoDx Prostate Test Data Publication in the Journal of Prostate Cancer and Prostatic Diseases. 10/13/2021 ... has published important clinical research in the journal Prostate Cancer and Prostatic Diseases , entitled Predicting high- ... Bio-Techne Corporation announced that scientists at the U.S. Centers for Disease Control and Prevention recently highlighted ...
Prostatic Diseases / classification* * Prostatic Diseases / diagnostic imaging * Seminal Vesicles / diagnostic imaging ... traditional prostatic utricle cyst); (ii) type 2a (60 cases), MLC with communication into the urethra (cystic dilatation of the ... prostatic utricle, CDU); (iii) type 2b (14 cases), CDU which communicated with the seminal tract; (iv) type 3 (three cases), ...
Prostate Cancer and Prostatic Diseases. 2/20/2007. 10:283-287. [QxMD MEDLINE Link]. [Full Text]. ... Case report: recurrent hematuria and hematospermia due to prostatic telangiectasia in classic von Willebrands disease. Am J ... Hydatid disease, a parasitic infection caused by the Echinococcus worm, has also been associated with hematospermia. [25] ... 20] Yu and colleagues found that 11% of a cohort of 65 patients with genitourinary TB had hematospermia during their disease. [ ...
Prostate Cancer and Prostatic Disease. English ISSN: 1365-7852. EISSN: 1476-5608. FREE. 1997 - 2003. ... Infectious Diseases. Genetics. Microbiology. Neurology. Oncology. Physiology. more... 2. FMJ Impact Top 20 #21-40 #41-60 #61-80 ...
... prostatic disease; and congenital anomalies such as ectopic ureters.1,2 In the dog of the present report, this procedure ... Diseases of the canine uterus. Reprod Domest Anim 2012;47:318-322. ... Diseases of the canine uterus. Reprod Domest Anim 2012;47:318-322. ... Diseases of the canine uterus. Reprod Domest Anim 2012;47:318-322. ...
Emerging Infectious Diseases journal articles present leading scientific research in epidemiology of and information in ... infectious diseases. Explore letters, research articles, policy, historical reviews, dispatches. ... Hennenfent B. Prostatitis and Benign Prostatic Hyperplasia: Emerging Infectious Diseases?. Emerging Infectious Diseases. 1997;3 ... Prostatitis and Benign Prostatic Hyperplasia: Emerging Infectious Diseases? [PDF - 17 KB - 2 pages] B. Hennenfent Cite This ...
Prostatic carcinoma - palliative therapy of advanced disease.. * CONTRAINDICATIONS Menest should not be used in women with any ... 4. Gallbladder disease. A 2- to 4-fold increase in the risk of gallbladder disease requiring surgery in postmenopausal women ... a. Coronary heart disease and stroke. In the Womens Health Initiative study (WHI), an increase in the number of myocardial ... Inoperable progressing prostatic cancer - 1.25 to 2.5 mg three times daily. The effectiveness of therapy can be judged by ...
Prostatic Abscess Due to Idiopathic Granulomatous Disease: A Rare Complication of a Chameleon Disorder -Prostatic Abscess Due ...
There are many potential treatments for an enlarged prostate or benign prostatic hyperplasia (BPH). Many people look to green ... Metabolic syndrome and prostatic disease: Potentially role of polyphenols in preventive strategies. A review. International ... What is benign prostatic hyperplasia?. Medically reviewed by Kevin Martinez, MD. Benign prostatic hyperplasia (BPH) is an ... Benign prostatic hyperplasia is the medical term for an enlarged prostate. There is continuing research into alternative ways ...
Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia?. J Urol. 1978 Aug. 120 (2):266 ... Transrectal prostatic sonography as a useful diagnostic means for patients with chronic prostatitis or prostatodynia. Br J Urol ... Expressed prostatic fluid contains more than 10 white blood cells per high-power field, indicating prostatitis. ... To rule out the presence of prostatic abscess in selected patients, transrectal ultrasound may be performed. However, it is ...
Benign Prostatic Disease (BPH). *Bladder Cancer. *Elevated PSA. *Erectile Dysfunction. *Female Incontinence And Reconstruction ... kidney stone disease, genitourinary cancer, BPH, female urology, prosthetic surgery, and infertility. Dr. Morris is a ...
Sub-specialties: urologic oncology and prostatic disease. Virginia Urology, 9105 Stony Point Drive, 330-9105 ... Sub-specialties: sinus disease, pediatric ENT, head and neck oncology. Virginia Ear Nose and Throat, 161 Wads-worth Drive; 7485 ... Other specialty: pulmonary disease. Sleep Disorder Center of Pulmonary Associates of Richmond, 2354 Colony Crossing Place, ... Professor, Division of Pulmonary Disease, and medical director of the Center for Adult Critical Care at VCU Medical Center, ...
Categories: Prostatic Diseases Image Types: Photo, Illustrations, Video, Color, Black&White, PublicDomain, CopyrightRestricted ... The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. ... Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People ...
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. ... Prostate Cancer Prostatic Dis 2011 Jun; 14(2):155-161 Link. https://doi.org/10.1038/pcan.2010.55 ... Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People ...
  • Dr Allen's Device is used as self-management tool for non-cancerous prostate diseases treatment at home protecting men with BPH and chronic prostatitis from getting COVID-19 coronavirus in clinics and hospitals. (deccanchronicle.com)
  • This in turn is the cause of symptoms associated with benign prostatic hypertrophy, prostatitis or cancer. (rockwoodnaturalmedicine.com)
  • Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia? (medscape.com)
  • Transrectal prostatic sonography as a useful diagnostic means for patients with chronic prostatitis or prostatodynia. (medscape.com)
  • Prostatitis and benign prostatic hyperplasia (BPH) are two common conditions that affect the prostate. (healthline.com)
  • It is effective for restoration of prostate gland function at diseases of various genesis, including benign prostatic hypertrophy, prostate adenoma, chronic prostatitis, and for men of senior age groups for maintenance of reproductive system function. (kalinka-store.com)
  • The test is only prostate specific, and elevations may arise from benign diseases of the prostate such as benign prostatic enlargement and prostatitis. (health.am)
  • It is recommended by the American Cancer Society that males over the age of 40 receive yearly examinations for the presence of prostatic enlargement and cancer. (rockwoodnaturalmedicine.com)
  • To rule out the presence of prostatic abscess in selected patients, transrectal ultrasound may be performed. (medscape.com)
  • In forty-four patients with different prostatic lesions serum immunoglobulins and tissue deposited immunoglobulins were studied by single radial immunodiffusion technique, and direct immunofluorescence and immunoperoxidase (PAP) methods respectively. (jpgmonline.com)
  • Bio-Techne Corporation announced that scientists at the U.S. Centers for Disease Control and Prevention recently highlighted the importance of fixed tissue analysis for retrospective diagnosis of SARS-CoV-2 infection and characterization of viral strains, particularly for fatal cases in which no previous testing for SARS-CoV-2 was performed. (biospace.com)
  • This indicates a greater extent of disease at diagnosis, as the blood level of PSA -- a protein produced by the prostate gland -- is often elevated in men with the disease . (cbsnews.com)
  • This will include the tools that are available for diagnosis and treatment of these prostatic diseases. (weston.org)
  • In a proportion of prostate cancer patients, there is evidence of metastatic disease at diagnosis or the disease recurs as distant metastasis despite standard curative treatment. (thieme-connect.com)
  • See Prostate Cancer: Diagnosis and Staging , a Critical Images slideshow, to help determine the best diagnostic approach for this potentially deadly disease. (medscape.com)
  • The RD-Connect Genome-Phenome Analysis Platform: Accelerating diagnosis, research, and gene discovery for rare diseases. (cdc.gov)
  • Centers for Disease Control and Prevention. (cdc.gov)
  • The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. (cdc.gov)
  • The NAMCS is a national probability sample survey conducted by the Division of Health Care Statistics, National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC). (cdc.gov)
  • Dr Allen's Device treats benign prostatic hyperplasia (BPH) and chronic pelvic pain at home by improving blood circulation in the prostate tissue, thus prevents men from contracting COVID-19 coronavirus. (deccanchronicle.com)
  • Specifically, the new research describes a new application of terazosin (TZ) - a drug commonly used to treat benign prostatic hyperplasia and hypertension - to fight the progression of Parkinson's disease. (idibell.cat)
  • Enlarged prostate is also called benign prostatic hyperplasia (BPH) . (medlineplus.gov)
  • Also called benign prostatic hyperplasia. (goldbamboo.com)
  • For patient education information, see the Men's Health Center and Cancer Center , as well as Male Reproductive Organs and Functions , BPH (Prostate, Benign Prostatic Hyperplasia) , Prostate Infections , and Prostate Cancer . (medscape.com)
  • Benign prostatic hyperplasia is the medical term for an enlarged prostate. (medicalnewstoday.com)
  • Polyphenols are the active ingredients in green tea that may be responsible for helping manage benign prostatic hyperplasia or BPH. (medicalnewstoday.com)
  • Benign prostatic hyperplasia (BPH) and prostate cancer are two of the most common conditions that affect the prostate, a gland that's part of the male reproductive system. (webmd.com)
  • The word "benign" in benign prostatic hyperplasia means it's not cancer. (webmd.com)
  • Management of Benign Prostatic Hyperplasia: Could Dietary Polyphenols Be an Alternative to Existing Therapies? (frontiersin.org)
  • The incidence of benign prostatic hyperplasia (BPH) is gradually on the increase. (frontiersin.org)
  • Benign prostatic hyperplasia (BPH) is the most common urological condition among elderly men, affecting approximately half of men over 80 years of age. (frontiersin.org)
  • A new study provides more evidence that a high-fat diet is a potential cause of prostatic diseases, including benign prostatic hyperplasia and prostate cancer . (renalandurologynews.com)
  • One of its main pathologies is benign prostatic hyperplasia (BPH), the most common benign disease in older men. (intechopen.com)
  • In this organ, estrogens promote or limit cell proliferation depending on the activated receptor, with implications for the pathophysiology of benign prostatic hyperplasia (BPH) and prostate cancer (PCa). (intechopen.com)
  • [ 7 ] The PSA level also tends to rise in men with benign prostatic hyperplasia (BPH) and is a good marker for prostate volume. (medscape.com)
  • Benign prostatic hyperplasia (BPH) is nonmalignant adenomatous overgrowth of the periurethral prostate gland. (msdmanuals.com)
  • Principles of «4P Medicine» in the organization of health care in the context of urological diseases Changes in the electrolyte composition of urine under the influence of sodium hypochlorite. (ecuro.ru)
  • One hypothesis is the disease has become more aggressive, regardless of the change in screening," senior study author Dr. Edward Schaeffer, chair of urology at Northwestern University Feinberg School of Medicine and Northwestern Medicine, said in a statement. (cbsnews.com)
  • Richard K. Babayan, MD, Professor Emeritus and Chairman of Urology at Boston University School of Medicine and Chief of Urology at Boston Medical Center will cover everything you need to know about benign and malignant diseases of the prostate. (weston.org)
  • With the progression of the disease, patients may also experience dementia and other neurological disorders. (idibell.cat)
  • however, in some patients, hematospermia may be the first indicator of other urologic diseases or systemic disorders (see DDx/Diagnostic Considerations ). (medscape.com)
  • Used in conjunction with the serum prostatic acid phosphatase level (PAP), color-doppler ultra sound, and findings on physical examination, the probability of cancer of the prostate may be eliminated as an etiology without further testing. (rockwoodnaturalmedicine.com)
  • An evaluation of serum and tissue bound immunoglobulins in prostatic diseases. (jpgmonline.com)
  • Serum IgM levels were found reduced only in patients with prostatic carcinomas (80% of cases) as compared to controls. (jpgmonline.com)
  • During ejaculation, the prostate contracts and squirts prostatic fluid into the urethra. (medicalnewstoday.com)
  • As the lumen of the prostatic urethra narrows and lengthens, urine outflow is progressively obstructed. (msdmanuals.com)
  • In addition to these symptoms, a reduction in the force and caliber of urination is also characteristic of prostatic enlargement. (rockwoodnaturalmedicine.com)
  • Since the main symptoms are due to degeneration and loss of nerve cells in the brain through the dopamine signaling molecule, efforts to reduce the symptoms of pathology focus on pharmacological replacement with L-DOPA, the use of Dopamine agonists and anticholinergics or electrophysiological replacement after surgery (Deep Brain Stimulation), although they are options that do not cure or delay disease progression. (idibell.cat)
  • According to the conclusions, patients treated with terazosin showed less severe symptoms and a slower progression of Parkinson's disease. (idibell.cat)
  • What are the symptoms of prostate diseases? (medlineplus.gov)
  • Treatment depends on what prostate disease you have and which symptoms bother you most. (medlineplus.gov)
  • Upper motor neuron neurological disease results in increased urethral tone to the point where dangerously high pressures can be generated within the bladder as urine continues to accumulate. (vin.com)
  • Prior to a biopsy procedure, your veterinarian will look to see if their are any other diseases present by doing diagnostic tests such as checking blood count, testing the urine, chest x-ray, and check of the lymph nodes for swelling and lumps. (dog-health-guide.org)
  • The scope of the patients seen at University of Maryland runs the gamut of urologic diseases. (umms.org)
  • Prostate Cancer and Prostatic Diseases is a quarterly peer-reviewed medical journal covering all aspects of prostatic diseases, in particular prostate cancer, the subject of intensive basic and clinical research world-wide. (wikipedia.org)
  • A new study published in the Journal of Clinical Investigation describes an innovative drug treatment to protect dopamine-producing brain cells in people affected by Parkinson's disease. (idibell.cat)
  • Therefore, this chapter aims to update the preclinical and clinical evidence on the etiology of this disease, briefly describing the epidemiology, clinical manifestations, and therapeutic and preventive modalities in managing BPH. (intechopen.com)
  • The fact that men in 2013 who presented with metastatic disease had much higher PSAs than similar men in 2004 hints that more aggressive disease is on the rise," Schaeffer said. (cbsnews.com)
  • Also, see the Advanced Prostate Cancer: Signs of Metastatic Disease slideshow for help identifying the signs of metastatic disease. (medscape.com)
  • Before the PSA era, an abnormality in the prostate had to be palpably evident before a biopsy would be performed, and nearly 70% of men diagnosed with prostate cancer already had extraprostatic or metastatic disease. (medscape.com)
  • Under normal conditions, the cellular tissue of the prostate produces a protein termed prostatic specific antigen (PSA), so named because it is found primarily in the prostate gland. (rockwoodnaturalmedicine.com)
  • Prostatic specific antigen is also elevated with cancer of the prostate but is not diagnostic of that condition. (rockwoodnaturalmedicine.com)
  • Anti-inflammatory drugs - can lead to the development of cardiovascular diseases, stomach ulcers, liver and kidney problems, etc. (deccanchronicle.com)
  • Estrogens with and without progestins should not be used for the prevention of cardiovascular disease. (nih.gov)
  • In many countries, cancer ranks the second most common cause of death following cardiovascular diseases. (health.am)
  • Important anatomic structures in cases of malignant diseases are the neurovascular bundles, the rectoprostatic angle and the seminal vesicles. (ispub.com)
  • Dietary polyphenols have gained public interest in recent times due to their roles in the prevention of various diseases that implicate free radicals/reactive oxygen species. (frontiersin.org)
  • But the American Cancer Society has criticized the methods used in the latest study, saying a more accurate measure would be to look at the rates of disease and mortality, as opposed to simply counting the number of cases. (cbsnews.com)
  • Dietary patterns and prostatic diseases. (nih.gov)
  • 7. Any history of previous urinary tract disease or other disease? (vin.com)
  • [ 8 , 9 ] The advent of oral therapy transformed BPH from a surgical disease into a chronic medical condition and coincided with a decreased population incidence of adverse events secondary to BPH. (medscape.com)
  • Prostate Cancer and Prostatic Diseases is of interest to surgeons, oncologists and clinicians treating patients and to those involved in research into diseases of the prostate. (wikipedia.org)
  • Over the last couple of decades there has been a significant increase in the burden of prostatic diseases, notably prostate cancer, in Asian countries. (nature.com)
  • In this virtual issue of Prostate Cancer and Prostatic Diseases entitled "Best of Asia", the journal's Editor-in-Chief, Dr. Stephen Freedland, along with members of the editorial board in China, Drs. Dingwei Ye and Yao Zhu, selected the top articles published by authors in Asia over the past year. (nature.com)
  • In 2017 and 2018, several notable advances have been made in the care of men with advanced or metastatic prostate cancer, and Prostate Cancer and Prostatic Diseases provides important insights and perspectives around each of these major advances. (nature.com)
  • The Editor of Prostate Cancer and Prostatic Diseases is proud to share a selection of key papers that have published in the journal to celebrate 20 years of publication! (nature.com)
  • Contrary to belief, benign prostatic hypertrophy does not necessarily develop into prostatic cancer, the second leading form of cancer in males. (rockwoodnaturalmedicine.com)
  • Prostatic cancer is the second leading form of cancer in men in the Unites States. (rockwoodnaturalmedicine.com)
  • The report, published today in in Prostate Cancer and Prostatic Diseases, a journal from Nature, prompted researchers to question whether a recent trend of fewer men being screened may be contributing to the rise. (cbsnews.com)
  • Cancer is a major burden of disease worldwide. (health.am)
  • Le cancer du poumon arrivait en deuxième position chez les femmes à Bahreïn. (who.int)
  • Prostate Cancer Prostatic Dis. (medscape.com)
  • Thermobalancing therapy with Dr Allen's Device received a U.S. patent for chronic diseases treatment through utilised emitted body heat. (deccanchronicle.com)
  • Read more about how the device works in a scientific article: Innovative Thermobalancing therapy and Dr Allen's Device for the first time employ body energy to treat chronic prostatic diseases effectively, published by Springer Nature in a leading International Journal of Quality Innovation. (deccanchronicle.com)
  • 5. Acute or chronic decompensated lung diseases. (who.int)
  • Compliance with one of the two diagnostic criteria defined for each disease (CPRC, CCM). (who.int)
  • While conventional drugs such as the α1-adrenergic receptor antagonists and 5α-reductase inhibitors have been found to be useful in the treatment of BPH, the adverse side effects associated with their usage, have led to increased search for alternative means of managing this disease. (frontiersin.org)
  • While these conventional drugs have been found to be efficacious in the treatment of BPH, the adverse effects associated with them, ranging from impotence and gynaecomastia to orthostatic hypotension, abnormal ejaculation amongst others, have led to increased search for alternative means of managing this disease. (frontiersin.org)
  • The primary function of the prostate is to contribute prostatic fluid to semen. (medicalnewstoday.com)
  • Prostatic fluid contains components that make semen an ideal substance for sperm cells to live in, including enzymes, zinc, and citric acid. (medicalnewstoday.com)
  • Prostatic fluid is slightly acidic, but other components of semen make it alkaline overall. (medicalnewstoday.com)
  • The free PSA measurement is generally higher in men with benign disease, and a measurement of less than 15% suggests clinically significant or more aggressive disease. (health.am)
  • This information is more than 6 million deaths from this disease useful to public health authorities, decision- occur annually and approximately 7 mil- makers and researchers. (who.int)
  • Furthermore, some studies suggest there is a link between metabolic syndrome and diseases of the prostate. (medicalnewstoday.com)
  • Black ginger extract has a preventive effect on obesity and various metabolic diseases. (greenmedinfo.com)
  • After an overview of the normal anatomy the imaging features of common prostatic diseases with CT and its limitations are discussed. (ispub.com)
  • In this review an overview of the normal anatomy and common imaging findings in prostatic diseases is given. (ispub.com)
  • This makes it difficult to draw conclusions about any potential effects of testosterone administration on less common diseases in men. (elifesciences.org)